Civic Intelligence

T a G Treatment Action Group Inc.

990 • Fiscal year 2018 • EIN 13-3624785

Jan 01, 2018 to Dec 31, 2018 • Filed on Oct 29, 2019

Organization ProfileWWW.TREATMENTACTIONGROUP.ORG
90 Broad Street No 2503New York, NY 10004

(212) 253-7922

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

32nd percentile

0.02x

Higher debt load relative to assets than 32% of similar nonprofits.

2018 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2018

Liabilities / Revenue

33rd percentile

0.04x

Higher debt load relative to revenue than 33% of similar nonprofits.

2018 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2018

Net Margin

8th percentile

-39%

Higher net margin than 8% of similar nonprofits.

2018 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2018

Top Officer Pay

87th percentile

$171,084

Higher top officer pay than 87% of similar nonprofits.

Top officer pay equals 9.5% of source-year revenue.

2018 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2018

Asset Growth

86th percentile

29%

Faster asset growth than 86% of similar nonprofits.

2018 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2017 to 2018

Revenue Growth

9th percentile

-31%

Faster revenue growth than 9% of similar nonprofits.

2018 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2017 to 2018

Balance Sheet
Liabilities / Assets32nd percentile

Assets

Up

$3,322,765

Up $746,921 (+29%) from 2017

Net Assets

Up

$3,254,849

Up $759,734 (+30%) from 2017

Liabilities

Down

$67,916

Down $12,813 (-16%) from 2017

Revenue And Expenses
Liabilities / Revenue33rd percentileNet Margin8th percentile

Revenue

Down

$1,809,214

Down $809,916 (-31%) from 2017

Expenses

Down

$2,510,963

Down $131,373 (-5.0%) from 2017

Net Income

Down

-$701,749

Down $678,543 (-2924%) from 2017

Historical Trend

Balance Sheet Trend

Asset Growth86th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$6.0M$4.0M$2.0M$0Assets 2010: $2,248,827Liabilities 2010: $2,860Net Assets 2010: $2,245,9672010Assets 2011: $2,679,042Liabilities 2011: $23,023Net Assets 2011: $2,656,0192011Assets 2012: $2,851,951Liabilities 2012: $25,636Net Assets 2012: $2,826,3152012Assets 2013: $1,880,235Liabilities 2013: $41,213Net Assets 2013: $1,839,0222013Assets 2014: $3,811,240Liabilities 2014: $30,523Net Assets 2014: $3,780,7172014Assets 2015: $3,609,971Liabilities 2015: $20,734Net Assets 2015: $3,589,2372015Assets 2016: $2,592,218Liabilities 2016: $74,083Net Assets 2016: $2,518,1352016Assets 2017: $2,575,844Liabilities 2017: $80,729Net Assets 2017: $2,495,1152017Assets 2018: $3,322,765Liabilities 2018: $67,916Net Assets 2018: $3,254,8492018Assets 2019: $2,736,460Liabilities 2019: $71,965Net Assets 2019: $2,664,4952019Assets 2020: $4,649,413Liabilities 2020: $282,097Net Assets 2020: $4,367,3162020Assets 2021: $3,776,196Liabilities 2021: $356,091Net Assets 2021: $3,420,1052021Assets 2022: $3,549,278Liabilities 2022: $931,291Net Assets 2022: $2,617,9872022Assets 2023: $4,624,032Liabilities 2023: $1,012,949Net Assets 2023: $3,611,0832023Assets 2024: $3,839,139Liabilities 2024: $745,777Net Assets 2024: $3,093,3622024

Highlighted filing

2018

Assets$3,322,765
Liabilities$67,916
Net Assets$3,254,849
Open 2018 Filing

Operations Trend

Revenue Growth9th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$6.0M$4.0M$2.0M$0-$2.0MRevenue 2010: $1,912,416Expenses 2010: $2,198,624Net Income 2010: -$286,2082010Revenue 2011: $1,886,646Expenses 2011: $1,677,094Net Income 2011: $209,5522011Revenue 2012: $2,042,960Expenses 2012: $1,872,664Net Income 2012: $170,2962012Revenue 2013: $1,458,571Expenses 2013: $2,437,127Net Income 2013: -$978,5562013Revenue 2014: $4,424,915Expenses 2014: $2,483,220Net Income 2014: $1,941,6952014Revenue 2015: $2,230,880Expenses 2015: $2,419,194Net Income 2015: -$188,3142015Revenue 2016: $1,623,672Expenses 2016: $2,690,029Net Income 2016: -$1,066,3572016Revenue 2017: $2,619,130Expenses 2017: $2,642,336Net Income 2017: -$23,2062017Revenue 2018: $1,809,214Expenses 2018: $2,510,963Net Income 2018: -$701,7492018Revenue 2019: $2,174,190Expenses 2019: $2,764,544Net Income 2019: -$590,3542019Revenue 2020: $4,690,654Expenses 2020: $2,987,833Net Income 2020: $1,702,8212020Revenue 2021: $2,714,054Expenses 2021: $3,661,265Net Income 2021: -$947,2112021Revenue 2022: $2,911,955Expenses 2022: $3,714,073Net Income 2022: -$802,1182022Revenue 2023: $4,736,176Expenses 2023: $3,743,080Net Income 2023: $993,0962023Revenue 2024: $3,574,921Expenses 2024: $4,092,642Net Income 2024: -$517,7212024

Highlighted filing

2018

Revenue$1,809,214
Expenses$2,510,963
Net Income-$701,749
Open 2018 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2018 to Dec 31, 2018
Signed
Oct 29, 2019
Return Version
2018v3.1
Gross Receipts
$1,915,087
Mission and Program Overview

Mission

Tag works to ensure that all people with hiv, tb, or hcv receive lifesaving treatment, care, and information. Tag is science-based treatment activists working to expand and accelerate vital research and effective community engagement with research and policy institutions. Tag catalyzes open collective action by all affected communities, scientists, and policy makers to end hiv, tb, and hcv.

T.a.g. Treatment action group, inc. ("tag") is a not-for-profit organization incorporated under the laws of the state of new york. Founded in january 1992, tag is an independent, activist, and community-based research and policy think tank fighting for better treatment, prevention, a vaccine, and a cure for hiv, tuberculosis (tb), and hepatitis c virus (hcv). Tag works to ensure that all people with hiv, tb, or hcv receive lifesaving treatment, care, and information. Tag is science-based treatment activists working to expand and accelerate vital research and effective community engagement with research and policy institutions. Tag catalyzes open collective action by all affected communities, scientists, and policy makers to end hiv, tb, and hcv.the primary sources of revenue to tag are contributions and grants.

Balance Sheet Detail
LineBeginningEndChange
Assets
Savings and Temporary Cash Investments$1,936,569$1,524,329▼ $412,240
Pledges and Grants Receivable$88,411$1,216,871▲ $1,128,460
Prepaid Expenses and Deferred Charges$25,384$31,594▲ $6,210
Land, Buildings, and Equipment, Net$25,974$26,728▲ $754
Cash and Non-Interest-Bearing Accounts$12,543$9,902▼ $2,641
Accounts Receivable-$1,139-
Total Assets$2,575,844$3,322,765▲ $746,921
Other Assets Total$486,963$512,202▲ $25,239
Liabilities
Other Liabilities$55,069$42,520▼ $12,549
Accounts Payable and Accrued Expenses$25,660$25,396▼ $264
Total Liabilities$80,729$67,916▼ $12,813
Net Assets / Fund Balance
Unrestricted Net Assets$1,321,367$1,736,034▲ $414,667
Temporarily Rstr Net Assets$1,173,748$1,518,815▲ $345,067
Total Net Assets Fund Balance$2,495,115$3,254,849▲ $759,734
Total Liabilities and Net Assets / Fund Balance$2,575,844$3,322,765▲ $746,921

Asset Categories

AssetBook ValueDepreciationBasis
Equipment$16,055$46,783$62,838
Other Land Buildings$10,673$9,225$19,898
Other Assets Org$439,739--
Compensation and Service Providers
Top Officer Pay87th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Mark HarringtonExecutive DirectorFT$156,943$14,141$171,084
Erica M LessemDeputy Executive DirectorFT$111,578$14,111$125,689

Board Members and Trustees

NameTitle
Barbara HughesPresident
Bobby MclainDirector
David I SigalDirector
Dick DadeyDirector
Eddie PeltoDirector
Frank BuaDirector
Jameel JiwaniDirector
Jeff MendozaDirector
Jim AquinoDirector
Joy EpisallaDirector
Kevin GoetzDirector
Monte SteinmanDirector
Nick DebsDirector
Richard Lynn PhdDirector
Robert MonteleoneDirector
Robert W LennonDirector
Roy M Gulick Md MphDirector
Alby P Maccarone JrDirector (through 8/2018)
Jason I OsherDirector (through 8/2018)
Laura MorrisonSecretary/treasurer
Revenue and Support

Revenue Composition

Contributions and Grants
$1,781,719
Program Service Revenue
$15,945
Investment Income
$1,668
Other Revenue
$9,882
All Other Contributions
$1,494,649
Change in Net Assets
$-701,749

Noncash Contribution Practices

Property subject to holding requirements
No
Reviewed unusual noncash gifts
No
Third parties used for noncash contributions
No

Noncash Contributions

Contribution TypeContribution CountReported AmountValuation Method
Works of Art1$100,000Selling Value
Other Non Cash Contri Table2$20,650Fair Market Value
Total Noncash Contributions3$120,650-

Audited Revenue Reconciliation

Revenue per Audited Statements
$1,809,214
Revenue Not Reported on Financial Statements
$0
Revenue Not Reported on Form 990
$2,500
Total Revenue per Audited Statements
$1,811,714
Total Revenue per Form 990
$1,809,214
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Salaries, Compensation, and Employee Benefits$1,520,496
Other Expenses$946,408
Total Fundraising Expense$163,942
Grants and Similar Amounts Paid$44,059
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Other Salaries and Wages$820,533$150,637$62,514$1,033,684
Travel$277,577$1,303$2,030$280,910
Fees for Services Other$222,652$168$33,575$256,395
Other Employee Benefits$181,535$32,189$13,937$227,661
Occupancy$162,468$18,093$11,407$191,968
Current Officers, Directors, Trustees, and Key Employees$143,710$15,398$11,976$171,084
Payroll Taxes$70,443$12,187$5,437$88,067
Office Expenses$28,116$3,975$15,458$47,549
Conferences and Meetings$47,052$18$112$47,182
Grants to Domestic Orgs$42,772--$42,772
Information Technology$22,585$1,851$743$25,179
Fees for Services Accounting-$18,000-$18,000
Insurance$10,551$1,017$738$12,306
Depreciation Depletion$8,697$1,505$671$10,873
Other Expenses$1,925$2,747$2,052$6,724
Advertising$2,580$237-$2,817
Fees for Services Legal$1,206$1,269-$2,475
Foreign Grants$1,287--$1,287
Total Functional Expenses$2,084,902$262,119$163,942$2,510,963

Audited Expense Reconciliation

Line ItemAmount
Total Expenses per Audited Statements$2,513,463
Expenses per Audited Statements$2,510,963
Total Expenses per Form 990$2,510,963
Expenses Not Reported on Form 990$2,500
Expenses Not Reported on Financial Statements$0
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
Public Health Access Collaboration IncBrooklyn, NY-Advocacy$32,772
Act UpNew York, NY-Advocacy$10,000

International Summary

Offices
0
Employees
0
Spending
$215,069

International Compliance

Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No

International Activities

RegionActivityServicesOfficesEmployeesSpending
Europe (including Iceland and Greenland)Program ServicesIas 201800$89,537
Europe (including Iceland and Greenland)Program ServicesTb - Iuatld 2018 the Hague00$28,501
East Asia and the PacificProgram ServicesHcv - Mtaag Malaysia00$18,000
Europe (including Iceland and Greenland)Program ServicesTb - Geneva00$12,149
Russia and Neighboring StatesProgram ServicesHcv - Ghrn Tbilisi Rep of Georgia00$9,000
East Asia and the PacificProgram ServicesTb - Philippines00$8,999
South AmericaProgram ServicesTb - Brazil00$7,656
South AsiaProgram ServicesTb - India00$6,492
Sub-saharan AfricaProgram ServicesTb - South Africa00$5,922
Europe (including Iceland and Greenland)Program ServicesHcv - Easl00$5,155
Europe (including Iceland and Greenland)Program ServicesHcv - Inhsu 2018 Lisbon00$3,113
Sub-saharan AfricaProgram ServicesTB - COTE D'IVOIRE AFRICA00$2,944
Europe (including Iceland and Greenland)Program ServicesTb - Cab Amsterdam00$2,879
Europe (including Iceland and Greenland)Program ServicesHiv - 4rp Madrid00$2,277
Europe (including Iceland and Greenland)Program ServicesTb - Who Mdr Geneva00$1,823
Europe (including Iceland and Greenland)Program ServicesTb - Lithuania00$1,781
Middle East and North AfricaProgram ServicesHcv - Morocco00$1,548
Sub-saharan AfricaProgram ServicesTb - Kenya00$1,350
North AmericaProgram ServicesTb - Cab Canada00$1,149
Europe (including Iceland and Greenland)Program ServicesHcv - Malta00$764
Europe (including Iceland and Greenland)Program ServicesHcv - Paris00$741
Russia and Neighboring StatesProgram ServicesHcv - Georgia Ussr Cab00$654
Europe (including Iceland and Greenland)Program ServicesHcv - Hric Portugal00$649
North AmericaProgram ServicesTb - Uaem Montreal00$640
Europe (including Iceland and Greenland)Program ServicesTb - Uk00$314
Europe (including Iceland and Greenland)Program ServicesTb - Impaact00$305
East Asia and the PacificProgram ServicesTb - Cambodia00$278
Europe (including Iceland and Greenland)Program ServicesHcv - Wha Uk00$250
Sub-saharan AfricaProgram ServicesTb - Tanzania00$140
East Asia and the PacificProgram ServicesHcv - Inhsu Australia Fees00$59
Fundraising, Events, and Gaming
Fundraising activities
Yes
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Fundraising Direct Expenses$80,112
Fundraising Gross Income$80,112
Professional Fundraising Fees$0

Fundraising Events

EventGross ReceiptsGross RevenueDirect ExpensesNet Income
Riaa$259,476$80,112$10,936$69,176
Total Events$259,476$80,112$80,112$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
Yes
Subject to proxy tax
No
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Deferred Rent Liability$42,520
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

“A draft of form 990 was sent to members of the board of directors for review and approval. The audit committee reviewed the form 990 and reported to the executive committee and the board of directors before the return was filed with the irs.”

Form 990, Part VI, Section B, Line 12C

“Conflict of interest policy requires board members and key staff to complete an annual disclosure statement. The related individual will be excluded from the discussion and the voting process.”

Form 990, Part VI, Section B, Line 15

“Compensation for key employees is reviewed and approved by the executive director. Compensation for the executive director is reviewed and approved by the board of directors. This was last completed in 2018.”

Form 990, Part VI, Section C, Line 19

“The organization's governing documents are available upon request. Annual reports are available on the organization's website.”

Filing and Contact Details

Filer

Filer Name
Tag Treatment Action Group Inc
EIN
13-3624785
Phone
2122537922
Address
90 BROAD STREET NO 2503, NEW YORK, NY 10004

Signing Officer

Name
Laura Morrison
Title
Secretary/treasurer
Phone
2122537922
Signed
2019-10-29
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Laura Morrison
Formed
1992
Legal Domicile
Ny
Voting Board Members
18
Independent Board Members
18
Employees
17
Volunteers
29

Preparer

Firm
Lutz and Carr Cpas Llp
Address
551 FIFTH AVE SUITE 400, NEW YORK, NY 10176
Preparer
Michael Wallace
Phone
2126972299
Supplemental Narrative

Additional Explanations

Form 990, Part IX, Line 11G

“Consultants: program service expenses 219,109. Management and general expenses 0. Fundraising expenses 33,350. Total expenses 252,459. It consultants: program service expenses 3,543. Management and general expenses 168. Fundraising expenses 225. Total expenses 3,936.”

990, Part XI, Line 8

“Prior year net assets were adjusted to record revenue in the appropriate periods: ford foundation: $ 75,000 bill & melinda gates foundation: $ 1,425,000 discounting on long-term pledges:$ (38,517) total $ 1,461,483”

Financial Statement Notes

PART III, LINE 4:

“The art prints are sold as part of the ticket package for major donors of the research in action awards event and subsequently sold as individual editions.”

Raw XML AppendixShowing 400 of 875 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt025660
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt025396
IRS990/AccountsReceivableGrp/EOYAmt01139
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0T.A.G. TREATMENT ACTION GROUP, INC. ("TAG") IS A NOT-FOR-PROFIT ORGANIZATION INCORPORATED UNDER THE LAWS OF THE STATE OF NEW YORK. FOUNDED IN JANUARY 1992, TAG IS AN INDEPENDENT, ACTIVIST, AND COMMUNITY-BASED RESEARCH AND POLICY THINK TANK FIGHTING FOR BETTER TREATMENT, PREVENTION, A VACCINE, AND A CURE FOR HIV, TUBERCULOSIS (TB), AND HEPATITIS C VIRUS (HCV). TAG WORKS TO ENSURE THAT ALL PEOPLE WITH HIV, TB, OR HCV RECEIVE LIFESAVING TREATMENT, CARE, AND INFORMATION. TAG IS SCIENCE-BASED TREATMENT ACTIVISTS WORKING TO EXPAND AND ACCELERATE VITAL RESEARCH AND EFFECTIVE COMMUNITY ENGAGEMENT WITH RESEARCH AND POLICY INSTITUTIONS. TAG CATALYZES OPEN COLLECTIVE ACTION BY ALL AFFECTED COMMUNITIES, SCIENTISTS, AND POLICY MAKERS TO END HIV, TB, AND HCV.THE PRIMARY SOURCES OF REVENUE TO TAG ARE CONTRIBUTIONS AND GRANTS.
IRS990/AdvertisingGrp/ManagementAndGeneralAmt0237
IRS990/AdvertisingGrp/ProgramServicesAmt02580
IRS990/AdvertisingGrp/TotalAmt02817
IRS990/AllOtherContributionsAmt01494649
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0SABRINA GUERRERO-MORRIS
IRS990/BooksInCareOfDetail/PhoneNum02122537922
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt090 BROAD STREET NO 2503
IRS990/BooksInCareOfDetail/USAddress/CityNm0NEW YORK
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0NY
IRS990/BooksInCareOfDetail/USAddress/ZIPCd010004
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOfficerEntInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt012543
IRS990/CashNonInterestBearingGrp/EOYAmt09902
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd01
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt011976
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt015398
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt0143710
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt0171084
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd01
IRS990/ConferencesMeetingsGrp/FundraisingAmt0112
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt018
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt047052
IRS990/ConferencesMeetingsGrp/TotalAmt047182
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/ContriRptFundraisingEventAmt0179364
IRS990/CostOfGoodsSoldAmt025761
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt01781719
IRS990/CYGrantsAndSimilarPaidAmt044059
IRS990/CYInvestmentIncomeAmt01668
IRS990/CYOtherExpensesAmt0946408
IRS990/CYOtherRevenueAmt09882
IRS990/CYProgramServiceRevenueAmt015945
IRS990/CYRevenuesLessExpensesAmt0-701749
IRS990/CYSalariesCompEmpBnftPaidAmt01520496
IRS990/CYTotalExpensesAmt02510963
IRS990/CYTotalFundraisingExpenseAmt0163942
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt01809214
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd01
IRS990/DeductibleNonCashContriInd01
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/FundraisingAmt0671
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt01505
IRS990/DepreciationDepletionGrp/ProgramServicesAmt08697
IRS990/DepreciationDepletionGrp/TotalAmt010873
IRS990/Desc0SEE SCHEDULE OHIV PROGRAMIN 2017, ACCORDING TO THE DECEMBER 2018 UNAIDS REPORT, APPROXIMATELY 36.9 MILLION PEOPLE WERE LIVING WITH HIV, 1.8 MILLION BECAME NEWLY INFECTED, AND APPROXIMATELY ONE MILLION PEOPLE WORLDWIDE DIED OF HIV DISEASE - DESPITE THE EXISTENCE OF EFFECTIVE PREVENTION AND TREATMENT INTERVENTIONS, WHICH ARE NOT REACHING MANY WHO NEED THEM. THIS IMMENSE PUBLIC HEALTH FAILURE IS DUE TO A DENSE WEB OF MEDICAL, POLITICAL, AND ECONOMIC PROBLEMS. MOST OF THE WORLD'S PEOPLE LIVING WITH HIV RESIDE IN DEVELOPING COUNTRIES WHERE MANY OBSTACLES PREVENT THE WIDESPREAD DISTRIBUTION OF HIV DRUGS. BUT EVEN THE MOST EFFECTIVE EXISTING DRUGS HAVE SHORTCOMINGS, AND PEOPLE LIVING WITH HIV EVERYWHERE NEED BETTER TREATMENT STRATEGIES AND, ULTIMATELY, A CURE THAT CAN BE USED WORLDWIDE TO END THE EPIDEMIC ALONG WITH A SAFE AND EFFECTIVE HIV VACCINE. TAG'S HIV PROGRAM REVIEWS THE STATE OF RESEARCH ON ANTIRETROVIRAL DRUG DISCOVERY, DEVELOPMENT, DISSEMINATION, AND POSTMARKETING SURVEILLANCE. THE HIV PROGRAM ADVOCATES FOR ACCELERATED ACCESS TO TREATMENTS; INNOVATION IN THE DEVELOPMENT OF TREATMENTS THAT ARE ACTIVE AGAINST DRUG-RESISTANT HIV; AND DEVELOPMENT OF HIV TREATMENTS THAT ARE EASIER TO TAKE, ASSOCIATED WITH FEWER SIDE EFFECTS, AND AFFORDABLE TO HEALTH CARE SYSTEMS AND PEOPLE LIVING WITH HIV.TAG'S HIV PROGRAM WORKS WITH COMMUNITY MEMBERS, SCIENTISTS, AND POLICY MAKERS TO ENHANCE PUBLIC UNDERSTANDING OF THE SCIENCE OF HIV INFECTION, ADDRESS GAPS IN HIV RESEARCH, CRITIQUE RESEARCH EFFORTS, AND FOSTER CROSS-DISCIPLINARY COLLABORATIONS WITH THE AIM OF ACCELERATING RESEARCH ON HIV PATHOGENESIS AND THE DEVELOPMENT OF EFFECTIVE IMMUNE-BASED THERAPIES AND PREVENTIVE TECHNOLOGIES, WITH A PARTICULAR FOCUS ON RESEARCH ADVOCACY AROUND A CURE FOR HIV. PROGRAM STAFF ALSO WORKS ON DOMESTIC AND INTERNATIONAL TREATMENT GUIDELINES TO ENSURE THAT FORMULARY DETERMINATIONS AND PRESCRIBING PRACTICES ARE DRIVEN BY SOUND SCIENTIFIC DATA. THE HIV PROGRAM TRACKS AND ANALYZES RESOURCES DEVOTED TO HIV PREVENTION AND COMBINED PREVENTION TECHNOLOGIES. THE PROGRAM ADVOCATES FOR LOCAL, STATE, AND NATIONAL AGENCIES AND AIDS SERVICE ORGANIZATIONS TO HAVE INCREASED AWARENESS OF CURRENT PREVENTION TOOLS, ALONG WITH MYRIAD STRUCTURAL BARRIERS SLOWING THEIR UPTAKE, IN ORDER TO STOP TRANSMISSION OF HIV AND THUS END THE EPIDEMIC. PROGRAM MEMBERS WORK ON NEW YORK STATE GOVERNOR ANDREW M. CUOMO'S ENDING THE EPIDEMIC STRATEGY AND SERVE ON ITS ENDING THE EPIDEMIC SUBCOMMITTEE OF THE AIDS ADVISORY COUNCIL. THIS EFFORT IS PART OF A BROADER PROGRAM BY COMMUNITY ACTIVISTS, POLICY MAKERS, ADVOCATES, AND RESEARCHERS TO END THE EPIDEMIC BY STEMMING NEW INFECTIONS AND ENSURING THAT HIV-POSITIVE PEOPLE RECEIVE CARE, ARE RETAINED IN ACTIVE CARE, AND REMAIN VIRALLY SUPPRESSED. IN 2018, TAG WORKED WITH THE ACT NOW END AIDS (ANEA) COALITION TO PUBLISH A ROAD-MAP FOR A U.S. ENDING THE HIV EPIDEMIC PROGRAM, INCLUDING PROPOSALS TO END THE RELATED EPIDEMICS OF HEPATITIS C VIRUS (HCV), SEXUALLY TRANSMITTED INFECTIONS [STIS], AND TUBERCULOSIS (TB). IN 2018, TAG WORKED WITH PARTNERS IN ALABAMA, LOUISIANA, NORTH CAROLINA, TEXAS, AND IN JACKSON, MI, AND MEMPHIS, TN, TO ESTABLISH PARTNERSHIPS IN THOSE JURISDICTIONS TO CREATE LOCALLY-LED AND GOVERNED ENDING-THE-HIV-EPIDEMIC INITIATIVES.AS PART OF THE HIV PROGRAM, TAG'S BASIC SCIENCE, VACCINES, AND CURE PROJECT (BSVC) WORKS WITH HIV COMMUNITY MEMBERS, SCIENTISTS, AND POLICY MAKERS TO ENHANCE PUBLIC UNDERSTANDING OF THE SCIENCE OF HIV INFECTION, ADDRESS GAPS IN HIV RESEARCH, CRITIQUE THE RESEARCH EFFORT, AND FOSTER CROSS-DISCIPLINARY COLLABORATIONS TO ACCELERATE RESEARCH INTO UNDERSTANDING HOW HIV CAUSES DISEASE (HIV PATHOGENESIS) AND SPEED THE DEVELOPMENT OF EFFECTIVE IMMUNE-BASED THERAPIES, VACCINES, AND A CURE. TAG'S BSVC WORKS TO SUPPORT AND ACCELERATE RESEARCH INTO CURING HIV INFECTION; PROMOTE THE RIGOROUS EVALUATION OF NEW IMMUNE-BASED THERAPEUTIC APPROACHES, INCLUDING THERAPIES TO REDUCE IMMUNE ACTIVATION AND IMPROVE IMMUNE RECONSTITUTION; A
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt017
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt0637829
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt018000
IRS990/FeesForServicesAccountingGrp/TotalAmt018000
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt01269
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt01206
IRS990/FeesForServicesLegalGrp/TotalAmt02475
IRS990/FeesForServicesOtherGrp/FundraisingAmt033575
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt0168
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt0222652
IRS990/FeesForServicesOtherGrp/TotalAmt0256395
IRS990/ForeignActivitiesInd01
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/ProgramServicesAmt01287
IRS990/ForeignGrantsGrp/TotalAmt01287
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt09.60
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt12.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt30.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt40.10
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt50.10
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt60.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt70.10
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt80.10
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt90.10
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt100.70
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt110.20
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt120.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt131.20
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt140.10
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt151.20
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt160.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt171.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt180.40
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt191.20
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt2040.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt2140.00
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd8X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd9X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd10X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd11X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd12X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd13X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd14X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd15X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd16X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd17X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd18X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd19X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt90
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt100
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt110
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt120
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt130
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt140
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt150
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt160
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt170
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt180
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt190
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt2014141
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt2114111
IRS990/Form990PartVIISectionAGrp/PersonNm0BARBARA HUGHES
IRS990/Form990PartVIISectionAGrp/PersonNm1LAURA MORRISON
IRS990/Form990PartVIISectionAGrp/PersonNm2JIM AQUINO
IRS990/Form990PartVIISectionAGrp/PersonNm3FRANK BUA
IRS990/Form990PartVIISectionAGrp/PersonNm4DICK DADEY
IRS990/Form990PartVIISectionAGrp/PersonNm5NICK DEBS
IRS990/Form990PartVIISectionAGrp/PersonNm6JOY EPISALLA
IRS990/Form990PartVIISectionAGrp/PersonNm7KEVIN GOETZ
IRS990/Form990PartVIISectionAGrp/PersonNm8ROY M GULICK MD MPH
IRS990/Form990PartVIISectionAGrp/PersonNm9JAMEEL JIWANI
IRS990/Form990PartVIISectionAGrp/PersonNm10ROBERT W LENNON
IRS990/Form990PartVIISectionAGrp/PersonNm11RICHARD LYNN PHD
IRS990/Form990PartVIISectionAGrp/PersonNm12ALBY P MACCARONE JR
IRS990/Form990PartVIISectionAGrp/PersonNm13BOBBY MCLAIN
IRS990/Form990PartVIISectionAGrp/PersonNm14JEFF MENDOZA
IRS990/Form990PartVIISectionAGrp/PersonNm15ROBERT MONTELEONE
IRS990/Form990PartVIISectionAGrp/PersonNm16JASON I OSHER
IRS990/Form990PartVIISectionAGrp/PersonNm17EDDIE PELTO
IRS990/Form990PartVIISectionAGrp/PersonNm18DAVID I SIGAL
IRS990/Form990PartVIISectionAGrp/PersonNm19MONTE STEINMAN
IRS990/Form990PartVIISectionAGrp/PersonNm20MARK HARRINGTON
IRS990/Form990PartVIISectionAGrp/PersonNm21ERICA M LESSEM
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt130
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt140
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt150
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt160
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt170
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt180
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt190
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20156943
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt21111578
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt130
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt140
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt150
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt160
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt170
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt180
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt190
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt200
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt210
IRS990/Form990PartVIISectionAGrp/TitleTxt0PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1SECRETARY/TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt2DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt7DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt8DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt9DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt10DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt11DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt12DIRECTOR (THROUGH 8/2018)
IRS990/Form990PartVIISectionAGrp/TitleTxt13DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt14DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt15DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt16DIRECTOR (THROUGH 8/2018)
IRS990/Form990PartVIISectionAGrp/TitleTxt17DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt18DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt19DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt20EXECUTIVE DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt21DEPUTY EXECUTIVE DIRECTOR
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/Form990TFiledInd01
IRS990/FormationYr01992
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/SeparateBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd01
IRS990/FundraisingAmt0179364
IRS990/FundraisingDirectExpensesAmt080112
IRS990/FundraisingGrossIncomeAmt080112
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt018
IRS990/GovernmentGrantsAmt0107706
IRS990/GrantAmt042772
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt042772
IRS990/GrantsToDomesticOrgsGrp/TotalAmt042772
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt01915087
IRS990/GrossSalesOfInventoryAmt030136
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd01
IRS990/IndependentVotingMemberCnt018
IRS990/IndivRcvdGreaterThan100KCnt02
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartIXInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InformationTechnologyGrp/FundraisingAmt0743
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt01851
IRS990/InformationTechnologyGrp/ProgramServicesAmt022585
IRS990/InformationTechnologyGrp/TotalAmt025179
IRS990/InsuranceGrp/FundraisingAmt0738
IRS990/InsuranceGrp/ManagementAndGeneralAmt01017
IRS990/InsuranceGrp/ProgramServicesAmt010551
IRS990/InsuranceGrp/TotalAmt012306
IRS990/InvestmentIncomeGrp/ExclusionAmt01668
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt01668
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt020
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt056008
IRS990/LandBldgEquipBasisNetGrp/BOYAmt025974
IRS990/LandBldgEquipBasisNetGrp/EOYAmt026728
IRS990/LandBldgEquipCostOrOtherBssAmt082736
IRS990/LegalDomicileStateCd0NY
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd01
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0TAG WORKS TO ENSURE THAT ALL PEOPLE WITH HIV, TB, OR HCV RECEIVE LIFESAVING TREATMENT, CARE, AND INFORMATION. TAG IS SCIENCE-BASED TREATMENT ACTIVISTS WORKING TO EXPAND AND ACCELERATE VITAL RESEARCH AND EFFECTIVE COMMUNITY ENGAGEMENT WITH RESEARCH AND POLICY INSTITUTIONS. TAG CATALYZES OPEN COLLECTIVE ACTION BY ALL AFFECTED COMMUNITIES, SCIENTISTS, AND POLICY MAKERS TO END HIV, TB, AND HCV.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt02495115
IRS990/NetAssetsOrFundBalancesEOYAmt03254849
IRS990/NetIncmFromFundraisingEvtGrp/TotalRevenueColumnAmt00
IRS990/NetIncomeOrLossGrp/ExclusionAmt04375
IRS990/NetIncomeOrLossGrp/TotalRevenueColumnAmt04375
IRS990/NetUnrelatedBusTxblIncmAmt09341
IRS990/NoncashContributionsAmt0120650
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/FundraisingAmt011407
IRS990/OccupancyGrp/ManagementAndGeneralAmt018093
IRS990/OccupancyGrp/ProgramServicesAmt0162468
IRS990/OccupancyGrp/TotalAmt0191968
IRS990/OfficeExpensesGrp/FundraisingAmt015458
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt03975
IRS990/OfficeExpensesGrp/ProgramServicesAmt028116
IRS990/OfficeExpensesGrp/TotalAmt047549
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsSFAS117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt0486963
IRS990/OtherAssetsTotalGrp/EOYAmt0512202
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt013937
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt032189
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt0181535
IRS990/OtherEmployeeBenefitsGrp/TotalAmt0227661
IRS990/OtherExpensesGrp/Desc0PRINTING & PUBLICATIONS
IRS990/OtherExpensesGrp/Desc1DUES AND SUBSCRIPTIONS
IRS990/OtherExpensesGrp/Desc2MISCELLANEOUS
IRS990/OtherExpensesGrp/FundraisingAmt03292
IRS990/OtherExpensesGrp/FundraisingAmt12052
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt01472
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt153
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt22747
IRS990/OtherExpensesGrp/ProgramServicesAmt024673
IRS990/OtherExpensesGrp/ProgramServicesAmt114540
IRS990/OtherExpensesGrp/ProgramServicesAmt21925
IRS990/OtherExpensesGrp/TotalAmt029437
IRS990/OtherExpensesGrp/TotalAmt114593
IRS990/OtherExpensesGrp/TotalAmt26724
IRS990/OtherLiabilitiesGrp/BOYAmt055069
IRS990/OtherLiabilitiesGrp/EOYAmt042520
IRS990/OtherRevenueMiscGrp/BusinessCd0900099
IRS990/OtherRevenueMiscGrp/Desc0MISCELLANEOUS
IRS990/OtherRevenueMiscGrp/ExclusionAmt05507
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt05507
IRS990/OtherRevenueTotalAmt05507
IRS990/OtherSalariesAndWagesGrp/FundraisingAmt062514
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt0150637
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt0820533
IRS990/OtherSalariesAndWagesGrp/TotalAmt01033684
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PayrollTaxesGrp/FundraisingAmt05437
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt012187
IRS990/PayrollTaxesGrp/ProgramServicesAmt070443
IRS990/PayrollTaxesGrp/TotalAmt088067
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt088411
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt01216871
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt025384
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt031594
IRS990/PrincipalOfficerNm0LAURA MORRISON
IRS990/PriorPeriodAdjustmentsAmt01461483
IRS990/ProfessionalFundraisingInd00
IRS990/ProgramServiceRevenueGrp/BusinessCd0900099
IRS990/ProgramServiceRevenueGrp/Desc0OTHER PROGRAM INCOME
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt015945
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt015945
IRS990/ProgSrvcAccomActy2Grp/Desc0SEE SCHEDULE OHEPATITIS C VIRUS (HCV) PROGRAMHEPATITIS C-RELATED LIVER DISEASE IS A LEADING CAUSE OF DEATH AMONG PEOPLE LIVING WITH HIV AND IS A LEADING INFECTIOUS CAUSE OF ILLNESS AND DEATH. ACCORDING TO THE WORLD HEALTH ORGANIZATION (WHO), AT LEAST 2.3 MILLION PEOPLE LIVING WITH HIV AROUND THE WORLD HAVE BEEN INFECTED WITH THE HEPATITIS C VIRUS (HCV), 71 MILLION ARE LIVING WITH CHRONIC HCV INFECTION, AND 399,999 DIE EACH YEAR FROM DISEASE CAUSED BY HCV. HIV WORSENS HCV DISEASE PROGRESSION AND OUTCOMES. TAG'S HEPATITIS C VIRUS PROGRAM REVIEWS THE STATE OF RESEARCH ON HCV MONOINFECTION AND COINFECTION. IT ADVOCATES FOR BETTER CLINICAL TRIAL DESIGNS, AND ACCESS TO CURATIVE TREATMENT FOR ALL AFFECTED COMMUNITIES, AND IT CONTINUALLY MONITORS STANDARDS OF CARE FOR PEOPLE WITH HCV MONOINFECTION AND COINFECTION. THE PROGRAM WORKS IN COLLABORATION WITH THE HCV AND HIV COMMUNITIES, SCIENTISTS, GOVERNMENT, AND DRUG COMPANIES TO MAKE LIFESAVING INFORMATION AND CURATIVE HEPATITIS TREATMENTS UNIVERSALLY AVAILABLE. SINCE THE INTRODUCTION OF ALL-ORAL, SHORT-COURSE DIRECT-ACTING ANTIVIRALS (DAAS), TAG HAS COLLABORATED WITH PARTNERS GLOBALLY AND DOMESTICALLY TO EXPEDITE UNIVERSAL, AFFORDABLE ACCESS TO THESE TREATMENTS. TAG'S HEPATITIS C PROGRAM HAS BEEN AT THE FOREFRONT OF A GLOBAL AND DOMESTIC HCV TREATMENT ACCESS EDUCATION AND ADVOCACY MOVEMENT. THE PROGRAM HAS BEEN INSTRUMENTAL IN BUILDING A GLOBAL COALITION OF ACTIVISTS IN LOW- AND MIDDLE-INCOME COUNTRIES WHO ARE ADVOCATING FOR ACCESS TO THESE CURES AND FOR CARE FOR ALL PEOPLE WITH HCV. HOWEVER, DUE TO DISEASE PROGRESSION, SOBRIETY, AND ADHERENCE RESTRICTIONS IMPOSED BY GOVERNMENTS AND PAYERS, PRICING BARRIERS, LIMITED VOLUNTARY LICENSING BY ORIGINATOR COMPANIES, AND DELAYS IN DRUG REGISTRATION, MOST COUNTRIES CANNOT AFFORD TO INITIATE TREATMENT PROGRAMS WITH DAAS. WITHOUT ACCESS TO AFFORDABLE, HIGH-QUALITY GENERIC DAAS, GLOBAL TARGETS TO REDUCE HCV INCIDENCE AND MORTALITY WILL BE UNATTAINABLE. MOST PEOPLE IN NEED OF HCV TREATMENT WILL REMAIN UNTREATED, WHICH PERMITS HCV TO CONTINUE TO SPREAD. TAG'S TREATMENT ACTIVISM SHARES CAMPAIGN STRATEGIES AND ADVOCACY TOOLS WITH PARTNERS DOMESTICALLY AND IN AROUND THE WORLD.COMMUNITY EDUCATION, ORGANIZING AND EMPOWERMENT ARE A PREREQUISITE FOR SUCCESSFUL AND SUSTAINABLE ADVOCACY. TAG PARTICIPATES IN COMMUNITY CONSULTATIONS AND ADVOCATES FOR PEOPLE WHO ARE MOST AT RISK AND MOST UNDER-SERVED TO BE INVOLVED IN HCV PLANNING AND POLICY-MAKING PROCESSES. RECENT CAMPAIGNS PUT HARM REDUCTION APPROACHES AS CENTRAL TO CURBING THE HCV EPIDEMIC, AND THESE EFFORTS INCLUDE SUPPORTING THE ESTABLISHMENT OF SUPERVISED INJECTION FACILITIES AND SAFE CONSUMPTION SPACES. WITH HEPATITIS C, POLITICAL WILL AND RESOURCE MOBILIZATION ARE NEEDED AT THE HIGHEST LEVELS - INCLUDING UNITED NATIONS (UN) AGENCIES SUCH AS THE WORLD HEALTH ORGANIZATION (WHO) AND PRESSURE MUST BE KEPT ON ORIGINATOR AND GENERIC COMPANIES TO ACHIEVE PRICE REDUCTIONS AND REMOVE OTHER ACCESS BARRIERS.IN 2018, TAG WITH PARTNERS INTERVENED TO PROMOTE COMMUNITY EDUCATION AND MOBILIZATION, ACCELERATED HCV DIAGNOSIS, ACCESS TO HCV CURE WITH DAAS, AND REDUCED PRICES FOR THESE CURATIVE COMBINATION THERAPIES, AT MULTIPLE LEVELS INCLUDING GLOBALLY, WITH PARTNERS IN DEVELOPING AND DEVELOPED COUNTRIES, AND IN THE UNITED STATES AND IN NEW YORK STATE WHERE TAG WAS NAMED TO THE GOVERNOR'S TASK FORCE ON HCV ELIMINATION, WHICH WILL REPORT OUT ITS STRATEGY IN 2019. IN 2018, TAG AND PARTNERS SECURED INCREASED "FUNDING FOR HCV PREVENTION, TESTING, LINKAGE TO CARE, AND TREATMENT SUPPORT."
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt0319337
IRS990/ProgSrvcAccomActy2Grp/RevenueAmt02982
IRS990/ProgSrvcAccomActy3Grp/Desc0SEE SCHEDULE OTUBERCULOSIS (TB) PROGRAMACCORDING TO THE WORLD HEALTH ORGANIZATION 2018 REPORT, TUBERCULOSIS (TB), THE WORLD'S DEADLIEST INFECTIOUS DISEASE, CAUSED TEN MILLION NEW CASES IN 2017, CAUSING 1.6 MILLION DEATHS, 300,000 OF THEM AMONG PEOPLE LIVING WITH HIV. DESPITE BEING CURABLE, TB IS THE LEADING CAUSE OF DEATH FOR HIV-POSITIVE PEOPLE GLOBALLY. HIV SIGNIFICANTLY INCREASES THE RISK FOR DEVELOPING TB DISEASE. PEOPLE AT RISK FOR BOTH DISEASES REQUIRE TB AND HIV SERVICES THAT WORK TOGETHER. TAG'S TB/HIV PROGRAM STRENGTHENS COMMUNITY-DRIVEN ADVOCACY FOR BETTER TB AND TB/HIV RESEARCH, AND HIGH-QUALITY PROGRAMS AND POLICIES WORLDWIDE. THE PROGRAM EDUCATES, MOBILIZES, AND EMPOWERS COMMUNITIES TO INCREASE COMMUNITY UNDERSTANDING OF TB/HIV COINFECTION AND TO CATALYZE ACTION TO REDUCE NEW INFECTIONS, DEATHS, AND SUFFERING FROM TB AND TB/HIV. THE PROGRAM WORKS WITH RESEARCHERS, COMMUNITY ADVOCATES, POLICY MAKERS, AND GLOBAL COALITIONS TO INCREASE THE QUANTITY AND IMPROVE THE QUALITY OF RESEARCH THAT CAN LEAD TO SHORTER, EASIER TB TREATMENT, MORE ACCURATE DIAGNOSTICS, AND BETTER PREVENTIVE OPTIONS. THE TB/HIV PROGRAM CONVENES AND ORGANIZES THE GLOBAL TB COMMUNITY ADVISORY BOARD (TB CAB), A GROUP OF EXPERT, EXPERIENCED COMMUNITY MEMBERS WHO PARTICIPATE ACTIVELY IN ONGOING CONSULTATIONS WITH SPONSORS, FUNDERS, AND ORGANIZERS OF TB PRODUCTS IN DEVELOPMENT, PARTICULARLY NEW TREATMENTS, NEW REGIMENS, AND NEW DIAGNOSTIC TEST PLATFORMS AND ALGORITHMS. THE PROGRAM REGULARLY ADVISES AND CONSULTS WITH THE WORLD HEALTH ORGANIZATION (WHO) END TB PROGRAMME, THE STOP TB PARTNERSHIP, UNAIDS, UNITAID, THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA, THE U.S. CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC), THE FOOD AND DRUG ADMINISTRATION (FDA), THE NATIONAL INSTITUTES OF HEALTH (NIH) AND PARTICULARLY ITS NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) AND OFFICE OF AIDS RESEARCH, THE OFFICE OF THE GLOBAL AIDS COORDINATOR (OGAC) AND ITS SCIENTIFIC ADVISORY BOARD, USAID, AND TB RESEARCH NETWORKS AND CONSORTIA SUCH AS THE AIDS CLINICAL TRIALS GROUP (ACTG), THE INTERNATIONAL MATERNAL PEDIATRIC AND ADOLESCENT AIDS CLINICAL TRIALS (IMPAACT) NETWORK, THE TB TRIALS CONSORTIUM (TBTC), AND OTHERS ON RESEARCH AGENDA, STUDY DESIGN, IMPLEMENTATION, ANALYSIS, DISSEMINATION OF RESULTS, AND THEIR TRANSLATION INTO POLICIES AND PROGRAMS. IN 2018 TAG WORKED TO ADVOCATE FOR AMBITIOUS GLOBAL TB RESEARCH AND PROGRAM FUNDING TARGETS AT THE UNITED NATIONS HIGH-LEVEL MEETING ON TUBERCULOSIS AND PUBLISHED NUMEROUS ADVOCACY AND RESEARCH PUBLICATIONS ON TB FUNDING, PREVENTION, TREATMENT, AND DRUG AND DIAGNOSTICS PRICING AND ACCESS.
IRS990/ProgSrvcAccomActy3Grp/ExpenseAmt01127736
IRS990/ProgSrvcAccomActy3Grp/GrantAmt01287
IRS990/ProgSrvcAccomActy3Grp/RevenueAmt09518
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt02615931
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt032000
IRS990/PYInvestmentIncomeAmt01549
IRS990/PYOtherExpensesAmt01062360
IRS990/PYOtherRevenueAmt01650
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0-23206
IRS990/PYSalariesCompEmpBnftPaidAmt01479176
IRS990/PYTotalExpensesAmt02642336
IRS990/PYTotalProfFndrsngExpnsAmt068800
IRS990/PYTotalRevenueAmt02619130
IRS990/QuidProQuoContributionsInd01
IRS990/QuidProQuoContriDisclInd01

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2018 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$3,322,765
Liabilities
$67,916
Net assets
$3,254,849
Revenue
$1,809,214
Expenses
$2,510,963
Net income
-$701,749
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Facts available. Structured filing facts are available, but richer extracted sections are limited.$3.84$0.75$3.09$3.57$4.09$0.52
2023Detailed filing. Detailed filing data is available for this year.$4.62$1.01$3.61$4.74$3.74$0.99
2022Detailed filing. Detailed filing data is available for this year.$3.55$0.93$2.62$2.91$3.71$0.80
2021Detailed filing. Detailed filing data is available for this year.$3.78$0.36$3.42$2.71$3.66$0.95
2020Detailed filing. Detailed filing data is available for this year.$4.65$0.28$4.37$4.69$2.99$1.70
2019Detailed filing. Detailed filing data is available for this year.$2.74$0.07$2.66$2.17$2.76$0.59
2018Detailed filing. Detailed filing data is available for this year.$3.32$0.07$3.25$1.81$2.51$0.70
2017Detailed filing. Detailed filing data is available for this year.$2.58$0.08$2.50$2.62$2.64$0.02
2016Detailed filing. Detailed filing data is available for this year.$2.59$0.07$2.52$1.62$2.69$1.07
2015Detailed filing. Detailed filing data is available for this year.$3.61$0.02$3.59$2.23$2.42$0.19
2014Detailed filing. Detailed filing data is available for this year.$3.81$0.03$3.78$4.42$2.48$1.94
2013Detailed filing. Detailed filing data is available for this year.$1.88$0.04$1.84$1.46$2.44$0.98
2012Summary only. Only limited summary data is available for this year.$2.85$0.03$2.83$2.04$1.87$0.17
2011Summary only. Only limited summary data is available for this year.$2.68$0.02$2.66$1.89$1.68$0.21
2010Summary only. Only limited summary data is available for this year.$2.25$0.00$2.25$1.91$2.20$0.29